Ingo Tornus

Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes

Gerasimos Filippatos, Stefan D. Anker, Rajiv Agarwal et al. · Circulation · 2020 · 265 citations · Full text

Biosynthetic Studies on the α-Glucosidase Inhibitor Acarbose in <i>Actinoplanes</i> sp.:  2-<i>epi</i>-5-<i>epi</i>-Valiolone Is the Direct Precursor of the Valienamine Moiety

Taifo Mahmud, Ingo Tornus, Erin Egelkrout et al. · Journal of the American Chemical Society · 1999 · 66 citations

Biosynthetic Studies, Pharmacotherapy, Chemical Biology +20

Biosynthesis of the Validamycins:  Identification of Intermediates in the Biosynthesis of Validamycin A by <i>Streptomyces </i><i>h</i><i>ygroscopicus</i> var. <i>l</i><i>imoneus</i>

Haijun Dong, Taifo Mahmud, Ingo Tornus et al. · Journal of the American Chemical Society · 2001 · 58 citations

Biosynthetic Studies of ω-Cycloheptyl Fatty Acids in <i>Alicyclobacillus cycloheptanicus</i>. Formation of Cycloheptanecarboxylic Acid from Phenylacetic Acid

Bradley S. Moore, Kevin D. Walker, Ingo Tornus et al. · The Journal of Organic Chemistry · 1997 · 39 citations

Lipid Analysis, Biosynthesis, Biotransformation +15

Novel reactions of N-sulfonylamines with 3-dimethylamino-2H-azirines. Competitive formation of 1,2,5-thiadiazoles, 1,2,3-oxathiazoles and acrylamidines. X-Ray molecular structure of N-(4-dimethylamino-5-methyl-2-oxo-5-phenyl-5H-1,2λ⁶,3-oxathiazol-2-ylidene)benzamide

Ingo Tornus, Ernst Schaumann, Ḡunadi Adiwidjaja · Journal of the Chemical Society Perkin Transactions 1 · 1996 · 18 citations

Thiadiazoles 5, Heterocyclic, Competitive Formation +12